https://dx.doi.org/10.1111/dom.13559
Aims: To investigate efficacy, safety and usability of the GlucoTab system for glycaemic management using insulin glargine U300 in non-critically ill hospitalized patients with type 2 diabetes (T2D).
In this study, various errors in Diabetes management were analysed and compared in both a paper-based system and the GlucoTab digital system.
The S&B Award is an opportunity for Rudolf Sallinger Fonds (www.sallingerfonds.at) to reward research-based commercialisation ideas in their early stages. GlucoTab made it to the Top 10 (2nd – 10th ex-equo). This award reinforces the significant research achievements behind the GlucoTab solution.
“ONE CLEVER IDEA – FIVE MINUTES TO WOW THE JURY AND THE CROWD” was the idea behind how start-ups introduced their solutions to a high-ranking jury at the HIMSS Europe eHealth Summit Austria 2016. The Start-ups had five minutes to convince a jury of experts and key opinion leaders about their solution and business idea.
decide made it to second place with GlucoTab.
The Styrian Health Quality Award, the SALUS 2015, was awarded at a ceremony at the PlatformQ – SALUS 2015 event on the 18th of September 2015 at the Grazer Congress. The University Hospital of Graz, the Medical University of Graz and Joanneum Research – Health won the award for the ‘GlucoTab System: innovative blood sugar management via tablet at the point of care in hospitals’.
GlucoTab® clinical evaluation of 99 patients across 4 different wards at the University Hospital of Graz:
In this proof-of-concept study during the beginning stages of GlucoTab development, an algorithm for basal-bolus insulin therapy was integrated into the workflow of a hospital ward, and glycemic control and usability were evaluated.
